Cargando…

Estimation of the number of HCV-positive patients in Italy

BACKGROUND: HCV is one of the main causes of cirrhosis, hepatocellular carcinoma (HCC) and liver transplantation. AIM: The aim of this study was to estimate the number of living individuals diagnosed with hepatitis C in Italy. This study also aimed to stratify these subjects as diagnosed and cured,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardini, Ivan, Bartoli, Marco, Conforti, Massimiliano, Mennini, Francesco Saverio, Marcellusi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822946/ https://www.ncbi.nlm.nih.gov/pubmed/31671120 http://dx.doi.org/10.1371/journal.pone.0223668

Ejemplares similares

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study
por: Coppola, Carmine, et al.
Publicado: (2021)

Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2012)

Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2013)

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2018)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2014)

Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study
por: Coppola, C., et al.
Publicado: (2021)

Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy
por: Mennini, Francesco S, et al.
Publicado: (2018)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

An Analysis of the Social and Economic Costs of Breast Cancer in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021)

Costo-efficacia di IMI/CIL/REL rispetto a CMS+IMI per il trattamento di infezioni batteriche Gram-negative non sensibili ai carbapenemi
por: Paoletti, Martina, et al.
Publicado: (2023)

Valutazione delle conseguenze epidemiologiche ed economiche generate dal ritardo di trattamento dei pazienti HIV-positivi causato dalla pandemia COVID-19
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Analisi di costo-utilità di ceftolozano/tazobactam rispetto a meropenem in pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP)
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2022)

Analisi di impatto di budget di un nuovo sistema di cura in pazienti affetti da malattia di Parkinson
por: Bini, Chiara, et al.
Publicado: (2022)

Valutazione economica di treosulfan in pazienti sottoposti a trapianto allogenico di cellule staminali ematopoietiche
por: Bini, Chiara, et al.
Publicado: (2022)

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
por: Marcellusi, A., et al.
Publicado: (2021)

Cost of illness del carcinoma cutaneo a cellule squamose (CSCC)
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy
por: Andreoni, Massimo, et al.
Publicado: (2022)

Socio-economic impact of epilepsy in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Economic aspects in the management of diabetes in Italy
por: Marcellusi, A, et al.
Publicado: (2016)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy
por: Perrone, Valentina, et al.
Publicado: (2021)

HCV and immigration in Italy
por: Massimo, Galli, et al.
Publicado: (2018)

Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
por: Andreoni, Massimo, et al.
Publicado: (2021)

Estimates of the Number of People Living with HIV in Italy
por: Camoni, Laura, et al.
Publicado: (2014)

Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021)

Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study
por: Mennini, Francesco Saverio, et al.
Publicado: (2012)

COVID-19 outbreak reproduction number estimations and forecasting in Marche, Italy
por: Chintalapudi, Nalini, et al.
Publicado: (2020)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

The potential impact of PNNR on the management of patients with epilepsy
por: Mennini, Francesco Saverio
Publicado: (2022)

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
por: Fabiano, G., et al.
Publicado: (2022)

Correlates of HCV seropositivity among familial contacts of HCV positive patients
por: La Torre, Giuseppe, et al.
Publicado: (2006)

An estimation of the number of children requiring pediatric palliative care in Italy
por: Benini, Franca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnbrprmcjss0n6rt76c6o449jr